Apellis Pharmaceuticals Statistics
Total Valuation
APLS has a market cap or net worth of $2.17 billion. The enterprise value is $2.28 billion.
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
APLS has 125.68 million shares outstanding. The number of shares has increased by 2.96% in one year.
Current Share Class | 125.68M |
Shares Outstanding | 125.68M |
Shares Change (YoY) | +2.96% |
Shares Change (QoQ) | +0.75% |
Owned by Insiders (%) | 3.37% |
Owned by Institutions (%) | 82.50% |
Float | 84.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.78 |
Forward PS | 2.39 |
PB Ratio | 13.24 |
P/TBV Ratio | 13.24 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.94 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 2.86.
Current Ratio | 4.08 |
Quick Ratio | 3.40 |
Debt / Equity | 2.86 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.19 |
Financial Efficiency
Return on equity (ROE) is -103.82% and return on invested capital (ROIC) is -23.06%.
Return on Equity (ROE) | -103.82% |
Return on Assets (ROA) | -14.20% |
Return on Invested Capital (ROIC) | -23.06% |
Return on Capital Employed (ROCE) | -29.61% |
Revenue Per Employee | $1.09M |
Profits Per Employee | -$315,042 |
Employee Count | 710 |
Asset Turnover | 0.95 |
Inventory Turnover | 3.43 |
Taxes
In the past 12 months, APLS has paid $1.33 million in taxes.
Income Tax | 1.33M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.10% in the last 52 weeks. The beta is 0.72, so APLS's price volatility has been lower than the market average.
Beta (5Y) | 0.72 |
52-Week Price Change | -59.10% |
50-Day Moving Average | 21.51 |
200-Day Moving Average | 29.42 |
Relative Strength Index (RSI) | 34.14 |
Average Volume (20 Days) | 2,790,039 |
Short Selling Information
The latest short interest is 28.77 million, so 22.89% of the outstanding shares have been sold short.
Short Interest | 28.77M |
Short Previous Month | 26.83M |
Short % of Shares Out | 22.89% |
Short % of Float | 34.06% |
Short Ratio (days to cover) | 10.62 |
Income Statement
In the last 12 months, APLS had revenue of $775.84 million and -$223.68 million in losses. Loss per share was -$1.80.
Revenue | 775.84M |
Gross Profit | 314.68M |
Operating Income | -186.22M |
Pretax Income | -330.95M |
Net Income | -223.68M |
EBITDA | -184.42M |
EBIT | -186.22M |
Loss Per Share | -$1.80 |
Full Income Statement Balance Sheet
The company has $362.34 million in cash and $469.55 million in debt, giving a net cash position of -$107.22 million or -$0.85 per share.
Cash & Cash Equivalents | 362.34M |
Total Debt | 469.55M |
Net Cash | -107.22M |
Net Cash Per Share | -$0.85 |
Equity (Book Value) | 164.22M |
Book Value Per Share | 1.31 |
Working Capital | 549.34M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$8.29 million and capital expenditures -$118,000, giving a free cash flow of -$8.41 million.
Operating Cash Flow | -8.29M |
Capital Expenditures | -118,000 |
Free Cash Flow | -8.41M |
FCF Per Share | -$0.07 |
Full Cash Flow Statement Margins
Gross margin is 40.56%, with operating and profit margins of -24.00% and -28.83%.
Gross Margin | 40.56% |
Operating Margin | -24.00% |
Pretax Margin | -28.66% |
Profit Margin | -28.83% |
EBITDA Margin | -23.77% |
EBIT Margin | -24.00% |
FCF Margin | n/a |
Dividends & Yields
APLS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.96% |
Shareholder Yield | n/a |
Earnings Yield | -10.29% |
FCF Yield | -0.39% |
Dividend Details Analyst Forecast
The average price target for APLS is $39.06, which is 125.78% higher than the current price. The consensus rating is "Buy".
Price Target | $39.06 |
Price Target Difference | 125.78% |
Analyst Consensus | Buy |
Analyst Count | 19 |
Revenue Growth Forecast (5Y) | 17.58% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
APLS has an Altman Z-Score of -0.4 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.4 |
Piotroski F-Score | 4 |